Beyond JAK2 Inhibitors: A Systematic Review of Management Strategies for Myelofibrosis

被引：0

作者：

Khan, Ali Younas ^{[1
]}

Iftikhar, Nimra ^{[1
]}

Ijaz, Awais ^{[1
]}

Tariq, Muhammad Junaid ^{[1
]}

Jamil, Faiza ^{[1
]}

Akbar, Arshia ^{[1
]}

Qureshi, Anum ^{[2
]}

Jose, Jemin Aby ^{[1
]}

Kamal, Ahmad ^{[1
]}

Abu Zar, Muhammad ^{[1
]}

Shafqat, Madeeha ^{[1
]}

Selene, Insija Ilyas ^{[1
]}

Aslam, Shehroz ^{[1
]}

Anwer, Faiz ^{[1
,3
]}

机构：

[1] Univ Arizona, Div Hematol & Oncol, Dept Med, Tucson, AZ USA

[2] Univ Arizona, Div Hematol & Oncol, Dept Med, Woodbridge, VA USA

[3] Cleveland Clin, Taussig Canc Ctr, Med Oncol, Dept Hematol, Cleveland, OH 44106 USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-115867

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

5484

引用

页数：4

共 50 条

[1] Myelofibrosis, JAK2 inhibitors and erythropoiesis
Vainchenker, W.
Favale, F.
LEUKEMIA, 2013, 27 (06) : 1219 - 1223
[2] Myelofibrosis, JAK2 inhibitors and erythropoiesis
W Vainchenker
F Favale
Leukemia, 2013, 27 : 1219 - 1223
[3] Therapy of myelofibrosis (excluding JAK2 inhibitors)
Alessandro Rambaldi
International Journal of Hematology, 2010, 91 : 180 - 188
[4] Therapy of myelofibrosis (excluding JAK2 inhibitors)
Rambaldi, Alessandro
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2010, 91 (02) : 180 - 188
[5] Myelofibrosis in 2019: moving beyond JAK2 inhibition
Schieber, Michael
Crispino, John D.
Stein, Brady
BLOOD CANCER JOURNAL, 2019, 9 (9)
[6] Myelofibrosis in 2019: moving beyond JAK2 inhibition
Michael Schieber
John D. Crispino
Brady Stein
Blood Cancer Journal, 9
[7] The pharmacotherapeutic management of patients with myelofibrosis: looking beyond JAK inhibitors
Duminuco, Andrea
Vetro, Calogero
Giallongo, Cesarina
Palumbo, Giuseppe Alberto
EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (13) : 1449 - 1461
[8] Management of MPN beyond JAK2
Harrison, Claire N.
Garcia, Natalia Curto
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2014, : 348 - 354
[9] Improved Efficacy Of Combination Of JAK2 and Hedgehog Inhibitors In Myelofibrosis
Bhagwat, Neha
Keller, Matthew D.
Rampal, Raajit K.
Shank, Kaitlyn
de Stanchina, Elisa
Rose, Kristine
Amakye, Dereck
Levine, Ross L.
BLOOD, 2013, 122 (21)
[10] Current treatment algorithm for the management of patients with myelofibrosis, JAK inhibitors, and beyond
Harrison, Claire N.
McLornan, Donal P.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 489 - 497

← 1 2 3 4 5 →